Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plusoptix is a healthcare and medical device company focused on binocular infrared photorefraction systems used for pediatric vision screening and refraction assessment. The company is best known for its Plusoptix vision screeners, which are used by pediatricians, ophthalmologists, optometrists, and screening programs to detect amblyopia risk factors such as refractive error, anisometropia, and strabismus-related findings. Its business appears to center on commercial ophthalmic screening devices rather than therapeutic drug development. Plusoptix operates in the eye care and diagnostics segment, with products positioned for early detection of visual disorders in children and other patients who may be difficult to test with conventional methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plusoptix.